NCT01285557 2024-09-19
DIGEST
Taiho Oncology, Inc.
Phase 3 Terminated
Clinical Trials
9 trialsNCT01761461 2020-03-25
ARTIST-II
Samsung Medical Center
Phase 3 Unknown
NCT00216034 2016-06-07
Randomized Controlled Study of Postoperative Adjuvant Therapy for Gastric Cancer Using TS-1 or TS-1+PSK
Hokuriku-Kinki Immunochemotherapy Study Group
Phase 3 Completed
NCT01671449 2015-11-30
SOPP
Asan Medical Center
Phase 3 Completed
NCT00687843 2012-03-22
TMOG-GC01
Tokyo Metropolitan Oncology Group
Phase 3 Unknown
NCT00150670 2011-07-07
Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00152217 2011-07-07
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Taiho Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT00287768 2011-06-28
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 3 Completed
NCT00195572 2009-08-13
Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 3 Completed